Emerald Advisers’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-726,236
| Closed | -$15.2M | – | 290 |
|
|
2021
Q3 | $15.2M | Buy |
726,236
+123,478
| +20% | +$2.58M | 0.55% | 75 |
|
|
2021
Q2 | $10.7M | Sell |
602,758
-12,753
| -2% | -$226K | 0.39% | 96 |
|
|
2021
Q1 | $15.1M | Buy |
615,511
+93,209
| +18% | +$2.28M | 0.54% | 84 |
|
|
2020
Q4 | $17.7M | Buy |
522,302
+197,720
| +61% | +$6.69M | 0.59% | 76 |
|
|
2020
Q3 | $8.12M | Buy |
324,582
+138,442
| +74% | +$3.46M | 0.33% | 97 |
|
|
2020
Q2 | $6.28M | Buy |
+186,140
| New | +$6.28M | 0.27% | 109 |
|